COSMO PHARMACEUTICALS S.P.A
Cosmo announces management proposals for the Extraordinary Shareholders Meeting of November 14, 2014
Lainate, Italy - November 6, 2014 - Cosmo Pharmaceuticals S.p.A. (SIX: COPN)
With regards to the Extraordinary Shareholders' Meeting called on November 14, 2014 in order to resolve, among other items, the transfer of the registered office to Luxembourg, the Company informs that management shall propose the following to be resolved upon by shareholders:
1) | Transfer of Seat Approval of the transfer of the seat to Luxembourg Set-up of a threshold to withdrawals of 600.000 shares, meaning that if more than 600'000 shares are put back to the Company by withdrawing shareholders, then the resolution on the change of seat will be ineffective |
2) | Articles of Association of Cosmo Pharmaceuticals SA As available on the Company's web site |
3) | Board of Directors Appointment of a new Board of Directors composed of 8 members for a term of one year, such appointment being effective only upon the change of seat being effective: Mauro Severino Ajani as Chairman (previous) Alessandro Della Cha, as CEO and Executive Director (previous) Chris Tanner, Executive Director (previous) Friedrich von Bohlen und Halbach, Non Executive Director (previous) Dieter Enkelmann, Non Executive Director (previous) Maria Grazia Roncarolo, Non Executive Director (previous) And as new Members Patrizia Lucchetta, Non Executive Director (new) Pierre-Yves Collée, Non Executive Director (new) The summarized CVs of Patrizia Lucchetta and Pierre-Yves Collée are attached herein and are available on the Company's website. As the number of the Board members shall be even, the Chairman shall have a casting vote. |
4) | Appointment of the Auditing Company It is proposed that Mazars Luxembourg is named the Auditing Company for a period of one year starting from the registry into the Luxembourg Register of Commerce. |
Curriculum Vitaes of the two proposed new board members
Patrizia Luchetta
Luxembourgoise (born 1964),
Patrizia Luchetta has a Bsc (Hon) in Human Geography and a MA in Social Sciences from the Open University, Milton Keynes (UK) and a Master in Biotech Management from IE Business School, Madrid.
From 1990-1996 she was the personal assistant of the Chairman of the Board of the Luxembourg Stock Exchange, from 1996-2000 and 2003-2006 she was Parliamentary Attaché to the LSAP, and since 2006 she has been Director of Life Sciences and Technologies in the Ministry of the Economy and of Foreign Trade of Luxembourg.
Patrizia Lucheta is Vice Chairman of Integrated Biobank Luxembourg (non-profit), member of the board of Enovos International, Luxembourg (an Electric Utility Group), and member of the board of Laboratoire National de Santé (public establishment)
Pierre-Yves Collée
Belgian (born 1975),
Pierre-Yves Collée has a a degree in commercial Engineering (1998), a license in "Analyse, Contrôle et Révisorat (1999) and a Master in Finance & Insurance (2003) all from the H.E.C. Liège.
From 1998-1999 he was an auditor at E&Y Luxembourg, from 1999-2000 he was an auditor at KPMG Luxembourg, from 2000-2004 at Arval PHH Luxembourg, a subsidiary of BNP Paribas, from 2004-2011 he was VP of Business Implementation at Citigroup Luxembourg and since 2011 he is the founder and CEO of EasyNext S.a.r.l which provides advisory services in non-life, life insurance and investment matters.
| Provider | Channel | Contact | ||
|---|---|---|---|---|
|
Tensid Ltd., Switzerland www.tensid.ch |
newsbox.ch www.newsbox.ch |
Provider/Channel related enquiries marco@tensid.ch +41 41 763 00 50 |
